566 related articles for article (PubMed ID: 20571380)
41. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
42. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
Konstenius M; Jayaram-Lindström N; Beck O; Franck J
Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
[TBL] [Abstract][Full Text] [Related]
43. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
Dillon DC; Salzman IJ; Schulsinger DA
J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138
[TBL] [Abstract][Full Text] [Related]
44. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
Golubchik P; Sever J; Zalsman G; Weizman A
Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
[TBL] [Abstract][Full Text] [Related]
45. Dexmethylphenidate for attention deficit hyperactivity disorder.
Coury D
Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
[TBL] [Abstract][Full Text] [Related]
46. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
47. Stimulant use and trichotillomania.
Martin A; Scahill L; Vitulano L; King RA
J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):349-50. PubMed ID: 9549952
[No Abstract] [Full Text] [Related]
48. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
49. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
Golubchik P; Weizman A
Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
[No Abstract] [Full Text] [Related]
50. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
51. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
[TBL] [Abstract][Full Text] [Related]
52. The possible effect of methylphenidate on secondary encopresis in children with attention-deficit/hyperactivity disorder.
Bilgiç A
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):647. PubMed ID: 21130131
[No Abstract] [Full Text] [Related]
53. Disordered sleep in pediatric patients with attention deficit hyperactivity disorder: an overview.
Ganelin-Cohen E; Ashkenasi A
Isr Med Assoc J; 2013 Nov; 15(11):705-9. PubMed ID: 24511653
[TBL] [Abstract][Full Text] [Related]
54. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
[TBL] [Abstract][Full Text] [Related]
55. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
Paslakis G; Schredl M; Alm B; Sobanski E
Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
[TBL] [Abstract][Full Text] [Related]
56. Methylphenidate: abuse and addiction.
Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
[No Abstract] [Full Text] [Related]
57. Cmap ADHD and comorbid aggression algorithm.
Sharp BW
J Am Acad Child Adolesc Psychiatry; 2007 Jan; 46(1):1. PubMed ID: 17195721
[No Abstract] [Full Text] [Related]
58. Psychosis induced by the interaction between disulfiram and methylphenidate may be dose dependent.
Grau-López L; Roncero C; Navarro MC; Casas M
Subst Abus; 2012; 33(2):186-8. PubMed ID: 22489591
[TBL] [Abstract][Full Text] [Related]
59. Methylphenidate (Ritalin) use and abuse.
Crutchley A; Temlett JA
S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
[No Abstract] [Full Text] [Related]
60. Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
Kummer A; Teixeira A
Australas Psychiatry; 2008 Dec; 16(6):458-9. PubMed ID: 19034996
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
